What If You Could Help Improve Your Child’s Attention More Effectively?

Attention Training

Technology

Publications

Join Us

CogoLand: Attention Training Programme for Children

  Watch the video to see how Neeuro Powers this Breakthrough Technology!

CogoLand is a patented digital attention training programme based on Brain Computer Interface (BCI) technology developed through a decade’s worth of extensive research that improves attention in children.

✓ Have the means to train an essential learning skill!
✓ Use a fun and interactive game to help solve your children’s biggest issues with attention!
✓ Easily administer and track progress!

*The Technology is non-invasive and certified safe to use even for all ages!

Instant Benefits of Attention Training Technology

l

Portable

The solution has been packaged so you can easily use it anywhere.

}

Easy-to-use

It’s easy to use that you’ll have more time having fun during training.

Track Progress

Monitor mental states so you know how well the users are performing.

Growth

Promote this cutting-edge technology and be featured with by us.

Introducing SenzeBand and CogoLand

Neeuro’s core products offer an advanced method of brain training and precision in-monitoring cognitive performance.

CogoLand

CogoLand is a digital intervention solution based on Brain Computing Interface (BCI) technology developed at A*STAR’s Institute for Infocomm Research (I2R), as a result of a collaboration between IMH and Duke-NUS Medical School in Singapore. Neeuro licensed the technology that created CogoLand and developed it into a commercial product, which consists of the SenzeBand headband to track brain signals as well as the CogoLand mobile application.

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.

Patients will be required to pair the CogoLand mobile application with a Neeuro SenzeBand for the detection of brainwaves. Machine learning algorithms will capture and interpret the mental states of patients based on their brainwaves, and these subsequently drive various challenges within the game.

SenzeBand

SenzeBand is Neeuro’s non-invasive EEG headband that safely measures brain signals. Low-frequency signals on the forehead are picked up by four individual sensors, giving us four individual channels of brain signals.

The level of these frequencies reveals a user’s brain states. SenzeBand measures the user’s mental state in real-time.

This helps in accessing, training, and tracking cognitive skills and brain performance. It measures and tracks your attention, focus, mental workload and relaxation. And if you can measure it… you can improve it!

“Our technology can accurately quantify a person’s attention level in real-time using a machine learning algorithm and, from there, develop a unique patented personalised training programme using a feed-forward concept for cognitive training. Further improvements have been made in recent iterations by capitalising on the latest deep learning approaches with our large dataset.”
Dr. Cuntai Guan, PhD

IEEE Fellow and Professor, Scientific Adviser, Nanyang Technological University & Neeuro Pte Ltd

“At Neeuro, our aim is to utilise technology to enable positive change in the neurological agility and fitness of our users. We are privileged to be working with institutions such as the Institute of Mental Health, Duke-NUS (National University of Singapore) and A*STAR (Agency for Science, Technology and Research), in conjunction with our hardware partner Samsung, to explore the use of cutting-edge technology in order to achieve this aim.”
Dr. Alvin Chan, PhD

Chief Executive Officer & Co-Founder, Neeuro Pte Ltd

Our Publications

CogoLand E-Brochure
CogoLand E-Brochure (Click to access)
CogoLand Whitepaper
CogoLand Whitepaper (Click to access)
Nature Article
Nature Article (Click to access)
PLOSone Article
PLOSone Article (Click to access)

Concerned with the growing number of

Children with Attention Difficulties?

In fact, clinicians are concerned with the growing number of children having attention issues. Attention is a real challenge for many children, even if they’re not diagnosed with attention challenges. Poor attention leads to poor memory, decision making and problem-solving, key functions when it comes to learning.

Inattention, ADHD and Poor Focus

ADHD is a neurodevelopmental disorder that affects approximately 5% to 6% of children globally.

Common symptoms represented by 38% to 57% of ADHD children include poor focus.

An epidemiological study of 20 countries from the World Health Organization found that across high-, upper–middle-, and low-/lower–middle-income countries, the mean worldwide prevalence of ADHD was ~2.2% overall in children and adolescents (aged <18 years).

The current management for ADHD includes medication and behavioural interventions where a clinician teaches both the parents and child strategies to reduce ADHD symptoms.

Clinical Trial Results

Neeuro’s Chief Scientist Cuntai Guan, who headed A*Star’s Biomedical Technology Research department, in collaboration with IMH and Duke-NUS, ran a clinical trial for Children with ADHD within the ages 6 to 12 years old.

Using a gamified intervention solution, “CogoLand”, the user concentrates/focus and the avatar in the game will move.

In the latest clinical trial that involved 172 ADHD children, the results showed that children who received 8 weeks of intervention showed more significant improvement in their inattentive symptoms than those who did not receive intervention.

Here’s How We’ll Get Started As Partners:

1. We get on a quick call to see if we’re the right fit for each other.

2. We’ll ask some questions, and answer yours as well until we’re both happy to move on.

3. You’ll be guided by our team on our onboarding process so you can confidently  offer CogoLand to your clients. You also get all the following bonuses:

– Enterprise Dashboard to manage your clients and easily show results to their parents.
– Full training provided to you and your team to ensure fast & easy adoption!

IMPORTANT: Due to overwhelming response and request, slots are quickly running out. If you are interested in implementing the solution this year, contact us today!

The Team Behind Neeuro

Eddie Chau
Eddie Chau

Chairman & Founder

A serial entrepreneur who founded e-Cop, Brandtology, V-Key, with successful exits for both e-Cop and Brandtology.

Alvin Chan, PhD
Alvin Chan, PhD

Chief Executive Officer & Co-Founder

Formerly the Co-Founder and CTO of Brandtology (successfully exited and acquired by iSentia) with a background in computer security, big data, neural networks & artificial intelligence.

Calvin Wee
Calvin Wee

Chief Operating Officer

Regional Tech Sales and Marketing leader, with over 25 years of experience, leading teams across Asia in Apple, BlackBerry, JawBone, and ResMed.

Dr. Cuntai Guan, PhD
Dr. Cuntai Guan, PhD

Scientific Advisor

World-renowned scientist in brain-computer interface (BCI) research and a pioneer in medical applications using BCI.

Sudharshan T.
Sudharshan T.

Director, Business Development (India)

Develops growth sales strategies, tactics and action plans specializing in new business development and expansion in India.

Dr. Kai Liu, MD, PhD, MBA
Dr. Kai Liu, MD, PhD, MBA

Business Advisor (China)

A physician-turned entrepreneur who founded a digital health company-CareLinker, which develops big data analytics to improve outcomes of chronic diseases care in China.

Frequently Asked Questions

How do we know that the child is getting better in their ADHD symptoms and not just memorizing the games?

There is no memorising in CogoLand as the objective of the game is to get the child to focus and sustain their focus. During the game sessions, the attention level of the child is tracked. We monitor the average attention level for each session. Over the whole training course, the child becomes better at their attention control, and we can observe the average attention by session to be trending up.

How will I know if the programme is suitable for my patient and is it a ‘one size fits all’ solution?

CogoLand is designed for children with ADHD who have inattentive symptoms or a combination of inattentive and hyperactive. If the child is predominantly hyperactive, the intervention programme might not be suitable for him/her. CogoLand is a personalised training programme. Before starting the training, the child goes through a ‘Calibration Phase’. This is done under the supervision of a clinician. During Calibration, the child wears Neeuro’s SenzeBand, so his/her EEG data is collected. That data is then used to build the child’s personalised attention state model which is used to track how well the child is focusing during the training sessions.

Can the improvements/changes be seen throughout the rest of the child’s life or does it only have a short effect?

In the latest clinical trial using CogoLand, the intervention programme was done with children at several phases: 8-weeks of intensive training followed by maintenance training (3 sessions per month) over the course of 12 weeks. The researchers saw that Brain-Computer Interface (BCI)-based attention training programme can lessen ADHD symptoms and maintenance training may sustain these improvements.

Could CogoLand replace other treatments available in the market?

CogoLand is not intended to replace other treatment modalities in the market but is intended to be a complementary intervention. A multidisciplinary approach to managing ADHD is ideal. This could include medication, psychological, psycho-social and brain training intervention. While this is so, the reality is the dropout rate for children with ADHD undergoing these various programs can be significant due to factors such as concerns with having children take medicines, encountering side effects, the treatment being too expensive and/or time-consuming.

Medicines change the brain chemistry of the child with ADHD that could allow them to function in an orderly manner. Can BCI-based brain training do the same?

There are many medicines in the market that do manage ADHD symptoms. Often, it’s a question of whether the parent would want their child to take the medication. They are concerned not only with efficacy but also with safety. BCI-based brain training is not just a safe intervention but is also proven effective through the different ADHD assessments but also through brain scans.

Some parents are concerned with children using their gadgets and their screen time effects. Would the CogoLand sessions negatively impact their child’s screen time?

We are very much conscious about concerns over screen time. In CogoLand, the sessions are monitored and limited to 20 minutes. This ensures that we are only using the device to achieve the goal of getting the child to improve and sustain their attention level.

Explore Digital Attention Training for your Children Today!

Copyright © 2020 NEEURO, PTE LTD. All Rights Reserved.

We are looking for expansion partners in your country!

Looking to integrate our solutions to your company, school or private practice? Contact us and a great partnership awaits! Visit our Business Partnership Opportunities page for more information.

Thank you for submitting the form. Our team will be in contact with you as soon as we can.